Ventus Therapeutics

Ventus sells its lead drug candidate to Novo Nordisk
BioPharma Dive
Thu, 09/29/22 - 09:48 am
Ventus Therapeutics
Novo Nordisk
inflammatory diseases
VENT-01
Chasing Novartis and Roche, Ventus banks $140M to take inflammatory disease drug into the clinic
Fierce Biotech
Wed, 02/9/22 - 10:07 am
Ventus Therapeutics
Novartis
Roche
funding
inflammation
Ventus raises $100M to pursue NLRP3, crack undruggable targets
Fierce Biotech
Thu, 04/8/21 - 10:24 am
Ventus Therapeutics
funding
clinical trials
undruggable targets